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Abstract
Background: The exact mechanism of knee osteoarthritis (OA)-associated pain is unclear, whereas mixed evidence
of inflammatory pain and neuropathic pain has been noted. We aimed to investigate pain-related sensory
innervation in a monoiodoacetate (MIA)-induced model of OA.
Methods: Sixty of seventy female Sprague Dawley rats of six week-old underwent intra-articular MIA and
fluorogold (FG) retrograde neurotracer injection into their right (ipsilateral) knee, while their left knees were treated
with FG in saline as a control (contralateral knee). Other rats were treated with FG only bilaterally, and used as
controls. Rats were evaluated for tactile allodynia using von Frey hairs. Proinflammatory mediators in the knee soft
tissues, including tumor necrosis factor (TNF)-a, interleukin (IL)-6, and nerve growth factor (NGF), were quantified
using ELISAs to evaluate inflammation in the knee after 1, 4, 7,14,21, and 28 days post injection:. Dorsal root
ganglia (DRG) were immunostained for three molecules after 7,14,21, and 28 days post injection: calcitonin gene-
related peptide (CGRP), a marker of inflammatory pain; and activating transcription factor-3 (ATF3) and growth
associated protein-43 (GAP43), as markers for nerve injury and regenerating axons. The distribution of microglia in
the spinal cord were also evaluated, because they have been reported to increase in neuropathic pain states.
These evaluations were performed up to 28 days postinjection. P < 0.05 was considered significant.
Results: Progressive tactile allodynia and elevated cytokine concentrations were observed in ipsilateral knees.
CGRP-immunoreactive (-ir) ipsilateral DRG neurons significantly increased, peaking at 14 days postinjection, while
expression of FG-labeled ATF3-ir or ATF3-ir GAP43-ir DRG neurons significantly increased in a time-dependent
manner. Significant proliferation of microglia were found with time in the ipsilateral dorsal horn.
Conclusions: Pain-related characteristics in a MIA-induced rat OA model can originate from an inflammatory pain
state induced by the local inflammation initiated by inflammatory cytokines, and that state will be followed by
gradual initiation of neuronal injury, which may induce the neuropathic pain state.
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Knee osteoarthritis (OA) is a common chronic
degenerative disease characterized by loss of articular
cartilage components [1], affecting the entire joint
structure including the synovial membrane, fat pad, and
subchondral bone. The main clinical sign of OA is joint
pain, which has a yet to be clarified mechanism, whereas
several animal models have been developed for OA
research. The pathological models for OA include
intraarticular injection of monoiodoacetate (MIA) into
the rat femorotibial joint space, which has been reported
to produce a linear pathology with similarities to OA
[2,3] and significant pain-related behavior [4,5]. Regard-
ing the characteristics of the pain, a previous study has
indicated the coexistence of an inflammatory pain state,
chemically initiated by inflammatory mediators, and a
neuropathic pain state, physically initiated by nerve
injury, in the models [6]. However, the details of these
pain states are unclear. One of the sources of the pain is
considered to be local inflammation in knee joints, such
as that in the synovial membrane that is considered to
promote pathological OA [7-9] followed by the produc-
tion of several cytokines such as tumor necrosis factor
(TNF)-a, interleukins (IL) such as IL-1b and IL-6, and
nerve growth factor (NGF). These mediators further
contribute to OA pathogenesis by increasing cartilage
degradation and inducing hyperalgesia. TNF-a activates
sensory neurons directly via its receptors and initiates a
cascade of inflammatory reactions through the produc-
tion of ILs such as IL-1 and IL-6 [10,11]. In particular,
IL-6 is reported to have a complex role in OA patho-
genesis by initiating inflammatory responses such as the
production of tissue inhibitors of metalloproteinases-1,
which may act to limit cartilage damage through nega-
tive feedback [12]. NGF is reported to be upregulated in
human osteoarthritic chondrocytes and synovial fibro-
blasts, suggesting its important role in OA pathology
[13,14].
To describe inflammatory-related pain, evaluation at
the level of dorsal root ganglia (DRG) is also important.
DRG neurons are divided into three classes: large DRG
neurons responsible for proprioception [15], small DRG
neurons containing pain-related neuropeptides such as
substance P and calcitonin gene-related peptide (CGRP)
[16-18], and small DRG neurons without these neuro-
peptides that can be labeled with isolectin-B4 (IB4), a
structural protein from Griffonia simplicifolia [17,18].
CGRP has been reported to produce hyperalgesia, and
its elevation is suggested to produce a pain sensation
derived from inflammation [19]. Its expression in DRG
neurons has been reported to be increased in MIA-
induced OA models [20,21], although its time course
has yet to be reported. Other studies imply the existence
of nerve injury that may lead to neuropathic pain,
showing the increased expression of activating transcrip-
tion factor (ATF)-3-immunoreactive (ir) DRG neurons
by using rat MIA-induced OA models [22]. ATF3 is
reported to be a selective marker of cell damage follow-
ing nerve injury [23]. To clarify their association with
nerve injury, evaluating the expression of growth-asso-
ciated protein (GAP)-43 and ATF3 at the level of the
DRG may be useful because these molecules are ele-
vated in DRG neurons with regenerating axon fibers
after nerve injury, which may indicate the pathogenesis
of neuropathic pain. However, the expression of these
molecules has also not been investigated. Furthermore,
it may be important to examine at the level of the spinal
cord where glial cells such as microglia are reported to
play an important role in facilitating neuropathic pain
derived from neural injury followed by their prolifera-
tion, morphological changes, and increased expression
of glial markers, such as the ionized-calcium-binding
adapter molecule (Iba)-1 [24-26]. It has also been
reported that CGRP-containing sensory nerve fibers
emerge in the deepest layer of the dorsal horn of the
spinal cord [27]. However, as far as we know, no related
studies have evaluated the time course of these findings
in spinal cords of animals in OA models.
The present study aimed to investigate the time
course of pain-related mediators, particularly focusing
on both inflammatory and neuropathic pain-related
states by using local tissues and sensory innervation of
the peripheral nervous system including DRG and spinal
cords of an MIA-induced model of OA in rats.
Methods
All protocols for animal procedures were reviewed and
approved by the ethics committee of our institution and
followed the National Institutes of Health Guidelines for
the Care and Use of Laboratory Animals (1996 revision).
Intraarticular injection of MIA and retrograde neurotracer
Seventy female Sprague-Dawley rats weighing 200-300 g
at 6 weeks of age were prepared (CLEA, Tokyo, Japan).
All rats were anesthetized with an intraperitoneal (i.p.)
injection of sodium pentobarbital (40 mg/kg) and trea-
ted aseptically. For 60 animals their right knees were
treated with a single intraarticular injection of 2 mg of
MIA (Sigma-Aldrich, St. Louis, MO) and 2% of the ret-
rograde neurotracer FG (Fluorochrome, Denver, CO) in
25 μl of sterile saline. The solution was injected through
the patellar ligament by using a 27G needle with the leg
flexed at a 90° angle at the knee. The left knees were
treated with FG alone. The doses of the drugs were
based on previous literature [28,29]. Subsequently, right
knees with an intraarticular injection of MIA were
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were “contralateral.” The contralateral knee joints were
used as controls in the following experiments. The 10
animals left were treated with FG bilaterally, and used
as controls.
Behavioral testing for tactile allodynia (von Frey hairs)
Tactile allodynia was assessed by measuring withdrawal
thresholds to calibrated von Frey hairs just before the
injection and at points 1, 4, 7, 14, 21, and 28 days after
the intraarticular injection as done previously [6,28].
The test was performed by touching the plantar surface
of the hind paws of awake animals placed into a cham-
ber with a metal grid floor with von Frey hairs in
ascending order of force. A positive response was noted
if the paw was sharply withdrawn or there was flinching
upon application of the hair. Once a positive withdrawal
response was established, the paw was retested, starting
with the next descending von Frey hair until no
response occurred. The lowest amount of force required
to elicit a response was recorded as the PWT (in
grams). Statistical analysis for behavioral experiments
was conducted on raw data by using repeated measures
analysis of variance (ANOVA) followed by Tukey’s post-
hoc test (P < 0.05 was identified as significant).
Tissue preparation
After deep anesthesia, the soft tissues around each side
of the joint and cartilage including the synovium and
capsule were resected (n = 7, each). The other rats were
left with their bilateral knees untreated for histopatholo-
gic examination by using hematoxylin and eosin (H-E)
staining. The rats were then perfused transcardially with
0.9% saline, followed by 500 ml of 4% paraformaldehyde
in phosphate buffer fixative (0.1 M, pH 7.4). Bilateral
untreated limbs, bilateral L4 DRGs, and spinal cord at
the level of the lumbar enlargement were resected. The
resected limbs were prepared for histopathology, and
the DRG and spinal cord specimens were prepared for
immunohistology.
Histopathology of the knee joint
The resected limbs were cut at midfemur and midtibia
and immersed in buffered paraformaldehyde fixative at
4°C for 1 week. The specimens were continuously demi-
neralized in 10% EDTA for 2 weeks followed by stan-
dard histological techniques by using paraffin blocks for
subsequent coronal (dorsoventral) sectioning. The sam-
ples were serially sectioned in steps of 8 μm, stained
using H-E, and assessed by light microscopy.
ELISA of the local tissues
Samples obtained just before the injection (control) and
at points 1, 4, 7, 14, 21, and 28 days after the
intraarticular injection and were collected (n = 7, each).
The trimmed samples of soft tissue inside the knee, pro-
liferated synovial membrane and anterior to the lateral
capsule of the ipsilateral knees and anterior to the lat-
eral capsule of the contralateral knees, were cut into
pieces about 1 mm × 1 mm × 2 mm in size, well-rinsed
in PBS, frozen in liquid nitrogen, and then crushed into
powder and homogenized in a 200-μl lysis/extraction
reagent (Sigma-Aldrich). The samples were centrifuged
at 14,000 rpm for 10 min at 4°C, and then the superna-
tants were extracted for the assay. The concentrations
of the cytokines were measured using ELISA kits opti-
mized for each cytokine following each manufacturer’s
protocol as follows: IL-6 (R&D Systems, Minneapolis,
MN), TNF-a (R&D Systems), and NGF (Millipore,
Temecula, CA). The limits of sensitivity for the cyto-
kines measured were 14, < 5, and 10 pg/ml, respectively.
The total protein concentration in all samples was mea-
sured using the Lowry method by using a DC protein
assay kit (Bio-Rad Laboratories, Hercules, CA).
After the measurement with a microplate reader
(Iwaki, Tokyo, Japan), we converted the absolute cyto-
kine concentrations into corresponding concentrations
per mg total protein. We statistically evaluated the cyto-
kine concentrations by using nonrepeated ANOVA fol-
lowed by an SNK post hoc test.
IHC of the DRG and spinal cord specimens
Samples were prepared 7, 14, 21, and 28 days after the
intraarticular injection including control. The DRG and
spinal cord specimens were immersed in a buffered par-
aformaldehyde fixative at 4°C overnight and then
immersed in PBS containing 20% sucrose for 20 h at 4°
C. After freezing in liquid nitrogen, each specimen was
sectioned at 10-μmt h i c k n e s so nac r y o s t a t( L e i c a
Microsystems, CM3050S, Wetzlar, Germany). The speci-
mens were then treated for 90 min at room temperature
with a blocking solution consisting of PBS containing
0.3% Triton X-100 and 3% skim milk.
The DRG specimens were processed using a rabbit
antibody against CGRP (1:1000; Immunostar, Hudson,
WI) and a biotin-labeled antibody against IB4 (1:1000;
Molecular Probes, Eugene, OR) or a rabbit antibody
against ATF3 (1:50; Santa Cruz, Delaware, CA) and a
mouse antibody against GAP43 (1:1000, Millipore). The
spinal cord specimens were processed using a rabbit
antibody against Iba-1 (1:1000; Wako, Osaka, Japan).
After incubation with the diluted antibodies for 20 h
at 4°C, DRG sections were incubated with Alexa 488-
conjugated goat anti-rabbit IgG (for CGRP immunoreac-
tivity, 1:1000; Molecular Probes) and Alexa 594-strepta-
vidin conjugates (for IB4 binding, 1:1000; Molecular
Probes) or Alexa 488-conjugated goat anti-rabbit IgG
(for ATF3 immunoreactivity, 1:1000) combined with
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immunoreactivity, 1:1000; Molecular Probes). Spinal
cord specimens were incubated with Alexa 488-conju-
gated goat anti-rabbit IgG (for Iba-1 immunoreactivity,
1:1000). After each step, the sections were rinsed three
times in PBS. The immunostained sections were
observed using a fluorescence microscope (Olympus,
Tokyo, Japan) in a treatment-blinded manner. The num-
bers of FG-labeled CGRP-ir or IB4-binding DRG neu-
rons and FG-labeled ATF3-ir or ATF3-ir GAP43-ir
DRG neurons in the DRG sections were counted. Their
proportion to the total number of FG-labeled DRG neu-
rons was calculated respectively for each DRG sample.
The density of Iba-1-ir microglia per 100 mm
2 was cal-
culated for both ipsilateral and contralateral dorsal
horns. We statistically evaluated the distribution of
immunostained DRG neurons by using non-repeated
ANOVA with a post hoc SNK test and evaluated the
distribution of microglia by using a Mann-Whitney U
test.
Results
Confirmation of rat knee OA models induced by MIA
injection
The average weight of the animals was 275.3 ± 12.2 g
without any significant bias. All of the ipsilateral knees
treated with MIA showed OA-like changes with macro-
scopic swelling, deformity. The contralateral vehicle-
treated knees showed no changes following the injection
of FG in sterile saline. The histological appearance of
MIA-injected knees showed OA-like appearances such
as an extensive area of cartilage loss and degeneration,
subchondral bone collapse, and moderately well-defined
subchondral cystic structure (Figure 1A), whereas the
contralateral knees showed a normal appearance
(Figure 1B). Furthermore, the measured diameters of the
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Figure 1 Histological and behavioral evaluation. Histological H-E stained appearance of the epiphysis 28 days after intraarticular injection: (A)
ipsilateral and (B) contralateral. The scale bars are 2.0 mm. F: femoral condyle; T: tibial condyle, M: meniscus. The histological examination
revealed OA-like findings, such as an extensive area of cartilage loss and degeneration, subchondral bone collapse, and moderately well-defined
subchondral cystic structure, whereas that of the contralateral knee yielded normal findings. (C) Transverse diameter of the knees. The measured
diameter showed significant gradual increase in the ipsilateral knees as the postinjection period passed (P < 0.05). (D) Behavioral profile in the
von Frey hairs test. PWT; paw withdrawal threshold. Each point represents the mean value ± S.E. PWT significantly decreased after MIA injection
in the ipsilateral limbs from post-injection day 4 and showed a similar tendency to decrease from postinjection day 7 to 28.
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after day 7 (Figure 1(C)) (P < 0.05)
Behavioral testing for tactile allodynia (von Frey hairs)
We examined the behavioral profile for von Frey hair
testing, which records the lowest amount of force
required to elicit a response to needle stimulation on
the paw of the animals (paw withdrawal threshold,
PWT; in grams). Figure 1D shows the behavioral pro-
files of the ipsilateral and contralateral limbs. PWT was
significantly decreased beginning on postinjection day 4
in the MIA-treated ipsilateral limbs (P < 0.01), although
PWT did not significantly changed from day 7 through
the end of the experimental period. The vehicle-treated
contralateral limbs showed almost no response to the
maximum force (300 g) used throughout the study, thus
no significant PWT change was observed.
Cytokine enzyme-linked immunosorbent assay (ELISA)
Figure 2 shows the modified concentrations of
cytokines. The concentrations of TNF-a and IL-6 were
significantly elevated starting on day 1 after the injection
and continued to increase with its peak on day 4, and
they were gradually decreased as the postinjection per-
i o dp r o g r e s s e d( F i g u r e2 A ,2 B ) .T h ec o n c e n t r a t i o no f
NGF was significantly increased at 1 week after the
injection (P < 0.05), and the increasing continued after
this point (Figure 2C).
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Figure 2 Modified concentrations of cytokines.( A )T N F - a, (B) IL-6, and (C) NGF. The concentrations of TNF-a and IL-6 were significantly
elevated starting on day 1 after the injection and continued to increase with its peak on day 4, and they were gradually decreased as the
postinjection period progressed (P < 0.05; Figure 2A, 2B). The concentration of NGF was significantly increased at 7 days after the injection (P <
0.05), and the increasing continued after this point (Figure 2C).
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of the DRG
Figures 3 and 4 show typical fluorescence photomicro-
graphs of processed L4 DRG neurons. FG-labeled DRG
neurons, which innervate knee joints, were present at all
bilateral DRG levels (Figure 3A, 3E). No lateral bias in
the proportion of FG-labeled DRG neurons was
observed at the same DRG level. Small-, intermediate-,
and large-sized DRG neurons were included in each
specimen and were counted along with the FG-labeled
small-sized DRG neurons. Using a fluorescence micro-
scope, both CGRP-ir DRG neurons and IB4-binding
DRG neurons were observed (Figure 3B and 3C), and
without any overlaps between these DRG neurons (Fig-
ure 3D), and the average numbers of the FG-labeled
neurons did not show significant changes between each
time point (Figure 3E). Figure 3F shows the average
numbers of FG-labeled CGRP-ir or IB4-binding DRG
neurons. The expression of CGRP-ir in ipsilateral DRG
neurons had significantly increased after 7 days after the
injection compared with the expression in the contralat-
eral DRG neurons (P < 0.05), and the expression was
greater at 14 days (P < 0.05). However, the proportion
of IB4-binding DRG neurons showed no significant dif-
ference in their distribution throughout the postinjec-
tion period.
ATF3-ir DRG neurons were observed, but only in the
ipsilateral DRG. No ATF3-ir DRG neurons were
observed in the contralateral DRG throughout the
experimental period. Significant numbers of ATF3-ir
DRG neurons were observed in only the ipsilateral DRG
after 14 days after the injection, and their proportions
significantly increased as the postinjection period pro-
gressed (P < 0.05). FG-labeled ATF3-ir GAP43-ir DRG
neurons showed a similar increase in their expression (P
< 0.05).
Immunohistology of the dorsal horn of the spinal cord
Figures 5 show typical fluorescent photomicrographs of
the dorsal horn of the lumbar enlargement of the spinal
cord immunostained for Iba-1 (Figure 5).
Iba1-ir microglia were observed in dorsal horns bilater-
ally (Figure 5A), and those in the ipsilateral dorsal horn
exhibited proliferation and hypertrophy (Figure 5B) com-
pared with those on the contralateral side (Figure 5C).
The number of microglia in the ipsilateral dorsal horn
was significantly greater thant h a to nt h ec o n t r a l a t e r a l
side after 14 days after the injection, and it achieved a
peak at day 14 and 21. (Figure 5D) (P < 0.05).
Discussion
The present study showed that a rodent knee OA model
induced by MIA exhibited tactile allodynia with
decreased PWT and elevated proinflammatory mediators
in local tissues. At the DRG level, the proportion of
CGRP-ir DRG neurons innervating the knee joint signifi-
cantly increased, unlike that of IB4-binding DRG neu-
rons. Furthermore, the proportions of FG-labeled ATF3-
ir and FG-labeled ATF3-ir GAP43-ir DRG neurons were
significantly increased in the postinjection period. In the
spinal cord, more proliferation of microglia were
observed in the ipsilateral dorsal horn.
Histological and behavioral evaluation of the
MIA-induced OA model
MIA injection has been reported to cause joint pathol-
ogy via the inhibition of glycolysis, thereby targeting
avascular cartilage and causing chondrocyte death [30].
MIA-treated knees that were histologically evaluated in
the present study exhibited osteoarthritic histological
changes. The measurement of diameters of the knees
increased significantly after day 7, which indicates the
pathogenesis of knee OA in conjunction with the patho-
logical findings The distribution of the weights of the
animals showed no bias; therefore, the results of the von
Frey tests indicate escape behavior and not lifting from
physical loading. The significant decrease of PWT indi-
cated tactile allodynia pathogenesis, consistent with a
previous study [28]. This decrease is considered to result
from allodynia derived from central sensitization; the
increase in afferent signaling from the joint nociceptors
to the spinal cord neurons results in increased sensitiv-
ity of the spinal cord neurons to input from the joint,
rendering the spinal cord neurons hyperexcitable [31].
Some studies have noted “mirror pain” that could be
observed as a referred pain in the contralateral limb
[ 3 2 ] ,w h e r e a st h er e s u l t so ft h ep r e s e n ts t u d yd i dn o t
reveal significant evidence for this. This implies signifi-
cant laterality of the pathogenesis of OA pain-related
activities in the ipsilateral k n e e sc o m p a r e dw i t ht h a ti n
the contralateral knees.
Cytokine expression in the local tissues of the knee joints
In the present study, the production of TNF-a and IL-6
showed significant temporal increases prior to the eleva-
tion of NGF production. MIA injection, by inducing
chemical injury, might have induced the production,
and inflammactivation of chondrocytes or synovial
membranes, or both, is considered to play an important
role as mentioned in the background. The evidence
shows that normally quiescent chondrocytes, as well as
synovial cells, respond to repetitive excess mechanical
loading via stress-induced intracellular signals that med-
iate the production of proinflammatory mediators such
as cytokines and cartilage-degrading proteinases [33].
Another study found that synovial inflammation is a fac-
tor that likely contributes to dysregulation of chondro-
cyte function, favoring an imbalance between the
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same DRG neuron is positive for FG, ATF3-ir, and GAP43-ir. (D) Merged image acquired from Figures 4(B) and 4(C). In ATF3-ir GAP43-ir DRG
neurons, the nuclei and cytoplasm are stained green and red, respectively (E) The average numbers of the FG-labeled ATF3-ir/ATF3-irGAP43-ir
DRG neurons. The number of the appropriate cells was small but increased significantly after 14 days post-injection (F) The number of FG-
labeled ATF3-ir DRG neurons was significantly increased in the ipsilateral MIA-treated knees (P < 0.05), and these neurons were significantly more
prevalent 14 days after MIA injection (P < 0.05). FG-labeled ATF3-ir and GAP43-ir DRG neurons showed a similarly significant temporal increase
(P < 0.05). There were no ATF3-ir or ATF3-ir GAP43-ir neurons in the contralateral side.
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Page 8 of 12catabolic and anabolic activities of chondrocytes in
remodeling the extracellular cartilage matrix [34]. Thus,
the activated chondrocytes and synovial membranes
should be the major sources of the elevated proinflam-
matory mediators, among which TNF-a produced from
the activated chondrocytes or synovial membranes can
induce IL-6 upregulation and neuropathic pain in the
spinal cord and DRG [35]. In parallel, another study
found that IL-6 enhances the expression of TNF-a
receptors [36], thus these proinflammatory mediators
act in concert to provoke further inflammation. NGF is
generally reported to be involved in chronic inflamma-
tory or neuropathic pain states [37]. NGF is physically
produced in articular structures and expressed in nor-
mal and OA synovial tissues, being increased in synovial
inflammation, especially upon synovial tissue exposure
to TNF-a [14]. Thus, NGF production during inflamma-
tion might be involved in the modulation rather than in
the induction of the joint inflammatory response.
The findings of the present study suggest that the ele-
vated production of TNF-a and IL-6 in the acute phase
after MIA injection may have induced elevated produc-
tion of NGF and that these elevated proinflammatory
cytokines are involved in the modulation of joint
inflammation.
Evaluation of sensory innervation at different DRG and
spinal cord levels
The present study showed that sensory neurons inner-
vating the knee are predominantly CGRP-ir. The aver-
age numbers of the FG-labeled neurons did not
significantly change between each time point, which
indicates that there was no significant increase or
decrease of the neurons innervating the joint. CGRP-ir
DRG neurons are reported to be NGF-dependent and
critical to hyperalgesic responses induced by inflamma-
tion [38-40], which also means that these DRG neurons
are “sensitive” to increased levels of NGF [16-18]. This
m a ye x p l a i nt h ee v i d e n c ef o ri n c r e a s e dn u m b e r so f
CGRP-ir DRG neurons in the MIA-injected knees in the
present study, which may result from stimulation of the
peripheral nerve fibers by increased peripheral NGF
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Figure 5 Fluorescent photomicrographs of the dorsal horn of the spinal cord immunostained for Iba1 at 28 days after the injection
(A), (B) and (C) are magnifications of the 28 days specimen. Scale bars are (A) 1.0 mm and (B)-(C) 200 μm. Iba1-ir microglia were observed in
bilateral dorsal horns (A), and those in the ipsilateral dorsal horn showed proliferation and hypertrophy relative to those on the contralateral side.
(D) Quantified number of microglia. The ipsilateral dorsal horn microglia were significantly more abundant than those on the contralateral side
at after 14 days after the injection (P < 0.05).
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Page 9 of 12production initiated from local inflammation as pro-
posed previously.
T h ep r e s e n ts t u d ys h o w e de v i d e n c ef o ral o wp e r c e n -
tage of IB4-binding DRG neurons (less than 4%). This
approximately coincides with the findings of a previous
study that reported the sensory innervation of hip joints
[29], while another study reported a complete absence
of IB4-binding DRG neurons [41]. However, IB4-binding
DRG neurons may not be involved in pain generation
without any overlaps between CGRP-ir neurons.
The numbers of both ATF3-ir and ATF3-irGAP43-ir
FG-labeled DRG neurons showed significant temporal
increases compared with their levels on the contralateral
side. ATF3 is not thought be expressed during inflam-
mation [42], thus the increased expression of ATF3-ir in
DRG neurons suggests the evidence of gradually pro-
gressive nerve injuries. The pain behavior evaluated in
the hind paw using von Frey filaments is thought to be
radiational pain derived from allodynia from the pre-
vious studies. Therefore, we should consider that it is
not directly related to the neuronal damage indicating
ATF3 or GAP43 immunoreactivity. However, the results
of the present study suggest that both the behavioral
changes and ATF3 production in DRG changes 7-14
days after the injection are related to each other.
Simultaneously, the significant gradual increase in the
number of ATF3- and GAP43-ir DRG neurons implies a
restoration process of the injured nerves in addition to
the nerve injuries. The progressive nerve injury and
regeneration may have resulted from the degradation of
cartilage; the physical wearing of cartilage leads to expo-
sure and degradation of subchondral bone, where sen-
sory nerve ingrowth and pain-related mediators increase
[43]. Subsequently, the exposed nerve endings may
become physically injured, which can accelerate nerve
ingrowth into the subchondral bone. This can lead to
the temporally increased expression of ATF3 and
GAP43. The absolute values of the proportions of
ATF3-ir and ATF3-irGAP43-ir DRG are not very high.
However, we consider its significant existence in the
ipsilateral DRGs to be important. In stronger neuronal
models such as the sciatic nerve axotomy model, ATF3-
ir and GAP43-ir are frequently and clearly observed
[44]. Therefore, we can hypothesize that MIA injection
does not induce such drastic neuronal damage during
the acute phase but the neuronal damage accompanying
ATF3 immunoreactivity occurs as the neuronal damage
proceeds.
Furthermore, it has been suggested that the proliferat-
ing microglia should also play a crucial role as is already
mentioned in the background. Furthermore, increased
levels of proinflammatory cytokines such as TNF-a and
IL-6 produced after peripheral nerve injury have been
reported to induce neuropathic pain by enhancing the
activities of microglia in the spinal cord [45,46]. The
present study showed significant proliferation of micro-
glia in the ipsilateral dorsal horn in addition to the ele-
vated levels of proinflammatory cytokines, which can
contribute to the neuronal damage, which may lead to
the pathogenesis of neuropathic pain. In addition, the
changes in the dorsal horn of the spinal cord regarding
microglia were significant only in the ipsilateral dorsal
horn. In general, many changes in the nervous system
can occur bilaterally even when there is a unilateral dis-
ease, which was not observed in the present study. One
of the reasons for this is likely the post-injection period.
Therefore, future investigations should be performed for
longer periods
The findings above indicate that the MIA-induced OA
pain results from inflammation, which initiates an
inflammatory pain state, and subsequently, and neural
damage gradually arising along with progressive cartilage
degradation may induce a chronic state such as a neuro-
pathic pain state. Also infrapatellar fat pad is reported to
be a source of the pain in OA, thus we should take
these reports into consideration [47]. Considering trans-
lational research, this may have important implications
for targeted analgesic therapies. In addition to antiin-
flammatory therapies such as NSAIDs, which may be
mainly effective for the early treatment of OA, treatment
for neuropathic pain may be effective for OA patients in
metaphase.
The present study has some limitations. First, MIA-
induced OA is a chemically induced model. To clarify
the details, further investigation with other nonchemi-
cally induced pathological models, such as partial medial
meniscectomy, should be conducted. Second, the beha-
vioral test for tactile allodynia with von Frey hairs can
be somewhat inaccurate and depends on the responses
of the animals. To analyze the behavior of rats objec-
tively and correctly, it may be helpful to use an appara-
tus to analyze their behavior by using other methods
such as evaluating weight bearing in free-moving walk-
ing animals [48] as well as response to heat or measur-
i n gd i r e c tp r e s s u r et ok n e e s[ 4 9 ] .T h i r d ,t h es a m p l e s
from each knee were complex structures consisting of
synovium and capsules, and we did not investigate the
distribution of proinflammatory cytokines in each struc-
ture. The distribution of receptors and their expression
as well as cytokines themselves should be examined in
future studies. Fourth, the present study examined up to
4 weeks after MIA injection. As the neuropathic pain
state has a tendency to increase temporally, the behavior
of the inflammatory pain state may be important; there-
fore, further investigation with a longer postinjection
period may be needed. Lastly, we examined the knee
joints to confirm the visual absence of yellow leakage of
FG from and around the knee joints throughout the
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culation using fluorescence microscopy. We think the
effect of the leakage is counteracted by averaging the
data. Further study may be necessary to clarify whether
any leakage actually occurred.
Conclusions
The present study showed the characteristics and the
time course of pain-related sensory innervation in a
MIA-induced rodent knee OA model during a 28 days
postinjection period. The OA knee joint was predomi-
nantly innervated by CGRP-ir DRG neurons, which
were elevated in number in the postinjection period,
peaking after 14 days along with significant decreases in
PWT. Elevated numbers of proinflammatory cytokines
in the local tissue suggested the initiation of local
inflammation. At the same time, the gradual elevation in
the number of ATF3-irGAP43-ir DRG neurons and the
gradual proliferation of microglia in the dorsal horn of
the spinal cord demonstrated progressive nerve injury,
which can suggest the gradual initiation of the neuro-
pathic pain state along with the inflammatory pain state.
Acknowledgements
We received no funding regarding this work.
Author details
1Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba
University, Chiba, Japan.
2Department of Orthopaedic Surgery, Chiba Rosai
Hospital, Chiba, Japan.
3Teikyo University Chiba Medical Center, Chiba, Japan.
4Department of Neurobiology, Graduate School of Medicine, Chiba
University, Chiba, Japan.
Authors’ contributions
SO, TI, and MM designed and performed all of the experiments, analyzed
data, and drafted the paper. NO, GI, YE, HK, GA, TT, YA, TK, KT, and SO
supervised the project and edited the manuscript. All authors contributed to
data interpretation and have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 28 December 2010 Accepted: 16 June 2011
Published: 16 June 2011
References
1. Todhunter PG, Kincaid SA, Todhunter RJ, Kammermann JR, Johnstone B,
Baird AN, et al: Immunohistochemical analysis of an equine model of
synovitis-induced arthritis. Am J Vet Res 1996, 57:1080-1093.
2. Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P: Mono-
iodoacetate-induced experimental osteoarthritis: a dose-response study
of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997,
40:1670-1679.
3. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K: Monoiodoacetate-
induced histologic changes in subchondral bone and articular cartilage
of rat femorotibial joints: an animal model of osteoarthritis. Toxicol
Pathol 2003, 31:619-624.
4. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, et al:
Weight bearing as a measure of disease progression and efficacy of
anti-inflammatory compounds in a model of monosodium iodoacetate-
induced osteoarthritis. Osteoarthritis Cartilage 2003, 11:821-830.
5. Combe R, Bramwell S, Field MJ: The monosodium iodoacetate model of
osteoarthritis: a model of chronic nociceptive pain in rats? Neurosci Lett
2004, 370:236-240.
6. Bove SE, Laemont KD, Brooker RM, Osborn MN, Sanchez BM, Guzman RE,
et al: Surgically induced osteoarthritis in the rat results in the
development of both osteoarthritis-like joint pain and secondary
hyperalgesia. Osteoarthritis Cartilage 2006, 14:1041-1048.
7. Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M: Synovial
membrane inflammation and cytokine production in patients with early
osteoarthritis. J Rheumatol 1997, 24:365-371.
8. Fiorito S, Magrini L, Adrey J, Mailhe D, Brouty-Boye D: Inflammatory status
and cartilage regenerative potential of synovial fibroblasts from patients
with osteoarthritis and chondropathy. Rheumatology (Oxford) 2005,
44:164-171.
9. Pearle AD, Scanzello CR, George S, Mandl LA, Dicarlo EF, Peterson M, et al:
Elevated high-sensitivity C-reactive protein levels are associated with
local inflammatory findings in patients with osteoarthritis. Osteoarthritis
Cartilage 2007, 15:516-523.
10. Ohtori S, Takahashi K, Moriya H, Myers RR: TNF-α and TNF-α receptor type
1 upregulation in glia and neurons after peripheral nerve injury: studies
in murine DRG and spinal cord. Spine 2004, 29:1082-1088.
11. Pollock J, McFarlane SM, Connell MC, Zehavi U, Vandenabeele P,
MacEwan DJ, et al: TNF-alpha receptors simultaneously activate Ca2+
mobilisation and stress kinases in cultured sensory neurons.
Neuropharmacol 2002, 42:93-106.
12. Lotz M, Guerne PA: Interleukin-6 induces the synthesis of tissue inhibitor
of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J
Biol Chem 1991, 266:2017-2020.
13. Iannone F, De Bari C, Dell’Accio F, Covelli M, Patella V, Lo Bianco G,
Lapadula G: Increased expression of nerve growth factor (NGF) and high
affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes.
Rheumatology (Oxford) 2002, 41:1413-1418.
14. Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, Aloe L: Nerve growth
factor release by human synovial fibroblasts prior to and following
exposure to tumor necrosis factor-alpha, interleukin-1 beta and
cholecystokinin-8: the possible role of NGF in the inflammatory
response. Clin Exp Rheumatol 2003, 21:617-624.
15. Perry MJ, Lawson SN, Robertson J: Neurofilament immunoreactivity in
populations of rat primary afferent neurons: a quantitative study of
phosphorylated and non-phosphorylated subunits. J Neurocytol 1991,
20:746-758.
16. Averill S, McMahon SB, Clary DO, et al: Immunocytochemical localization
of trkA receptors in chemically identified subgroups of adult rat sensory
neurons. Eur J Neurosci 1995, 7:1484-1494.
17. Molliver DC, Radeke MJ, Feinstein SC, et al: Presence or absence of TrkA
protein distinguishes subsets of small sensory neurons with unique
cytochemical characteristics and dorsal horn projections. J Comp Neurol
1995, 361:404-416.
18. Snider WD, McMahon SB: Tackling pain at the source: new ideas about
nociceptors. Neuron 1998, 20:629-632.
19. Sun R, Tu Y, Lawand N, et al: Calcitonin gene-related peptide receptor
activation produces PKA- and PKC-dependent mechanical hyperalgesia
and central sensitization. J Neurophysiol 2004, 92:2859-2866.
20. Buma P, Verschuren C, Versleyen D, Van der Kraan P, Oestreicher AB:
Calcitonin gene-related peptide, substance P and GAP43/B-50
immunoreactivity in the normal and arthritic knee joint of the mouse.
Histochemistry 1992, 98:327-339.
21. Fernihough J, Gentry C, Bevan S, Winter J: Regulation of calcitonin gene-
related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett
2005, 388:75-80.
22. Ivanavicius SP, Ball AD, Heapy CG, Westwood FR, Murray F, Read SJ:
Structural pathology in a rodent model of osteoarthritis is associated
with neuropathic pain: increased expression of ATF3 and
pharmacological characterisation. Pain 2007, 128:272-282.
23. Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, et al: Activating
transcription factor 3 (ATF3) induction by axotomy in sensory and
motoneurons: a novel neuronal marker of nerve injury. Mol Cell Neurosci
2000, 15:170-182.
24. Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for
pathological pain. Trends Neurosci 2001, 24:450-455.
Orita et al. BMC Musculoskeletal Disorders 2011, 12:134
http://www.biomedcentral.com/1471-2474/12/134
Page 11 of 1225. DeLeo JA, Yezierski RP: The role of neuroinflammation and neuroimmune
activation in persistent pain. Pain 2001, 90:1-6.
26. Tsuda M, Inoue K, Salter MW: Neuropathic pain and spinal microglia: a
big problem from molecules in “small” glia. Trends Neurosci 2005,
28:101-107.
27. Nakamura S, Myers RR: Injury to dorsal root ganglia alters innervation of
spinal cord dorsal horn lamina involved in nociception. Spine 2000,
25:537-542.
28. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, et al: Pain
related behaviour in two models of osteoarthritis in the rat knee. Pain
2004, 112:83-93.
29. Nakajima T, Ohtori S, Yamamoto S, Takahashi K, Harada Y: Differences in
innervation and innervated neurons between hip and inguinal skin. Clin
Orthop Relat Res 2008, 466:2527-2532.
30. Janusz MJ, Bendele AM, Brown KK, Taiwo YO, Hsieh L, Heitmeyer SA:
Induction of osteoarthritis in the rat by surgical tear of the meniscus:
inhibition of joint damage by a matrix metalloproteinase inhibitor.
Osteoarthritis Cartilage 2002, 10:785-791.
31. Schaible HG: Neurophysiology of nociception and pain reactions in
inflammatory joint diseases. Rev Rhum Engl Ed 1997, 64:144S-145S.
32. Aloisi AM, Porro CA, Cavazzuti M, Baraldi P, Carli G: ’Mirror pain’ in the
formalin test: behavioral and 2-deoxyglucose studies. Pain 1993,
55:267-273.
33. Goldring MB, Goldring SR: Osteoarthritis. J Cell Physiol 2007, 213:626-634.
34. Loeser RF: Molecular mechanisms of cartilage destruction: mechanics,
inflammatory mediators, and aging collide. Arthritis Rheum 2006,
54:1357-1360.
35. Lee KM, Jeon SM, Cho HJ: Tumor necrosis factor receptor 1 induces
interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain
model. Eur J Pain 2009, 13:794-806.
36. Van Bladel S, Libert C, Fiers W: Interleukin-6 enhances the expression of
tumor necrosis factor receptors on hepatoma cells and hepatocytes.
Cytokine 1991, 3:149-154.
37. Pezet S, McMahon SB: Neurotrophins: mediators and modulators of pain.
Annu Rev Neurosci 2006, 29:507-538.
38. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J: Nerve growth
factor contributes to the generation of inflammatory sensory
hypersensitivity. Neuroscience 1994, 62:327-331.
39. Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, et al: Inhibition
of hyperalgesia by ablation of lamina I spinal neurons expressing the
substance P receptor. Science 1997, 278:275-279.
40. Koltzenburg M, Bennett DLH, Shelton DL, McMahon SB: Neutralization of
endogenous NGF prevents the sensitization of nociceptors supplying
inflamed skin. Eur J Neurosci 1999, 11:1698-1704.
41. Ivanavicius SP, Blake DR, Chessell IP, Mapp PI: Isolectin B4 binding neurons
are not present in the rat knee joint. Neuroscience 2004, 128:555-560.
42. Averill S, Michael GJ, Shortland PJ, Leavesley RC, King VR, Bradbury EJ, et al:
NGF and GDNF ameliorate the increase in ATF3 expression which occurs
in dorsal root ganglion cells in response to peripheral nerve injury. Eur J
Neurosci 2004, 19:1437-1445.
43. Ogino S, Sasho T, Nakagawa K, Suzuki M, Yamaguchi S, Higashi M, et al:
Detection of pain-related molecules in the subchondral bone of
osteoarthritic knees. Clin Rheumatol 2009, 28:1395-1402.
44. Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, et al: Activating
transcription factor 3 (ATF3) induction by axotomy in sensory and
motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosc
2000, 15:170-82.
45. Milligan ED, Twining C, Chacur M, Biedenkapp J, O’Connor K, Poole S, et al:
Spinal glia and proinflammatory cytokines mediate mirror-image
neuropathic pain in rats. J Neurosci 2003, 23:1026-1040.
46. Schafers M, Svensson CI, Sommer C, Sorkin LS: Tumor necrosis factor-alpha
induces mechanical allodynia after spinal nerve ligation by activation of
p38 MAPK in primary sensory neurons. J Neurosci 2003, 23:2517-2521.
47. Witoński D, Wagrowska-Danilewicz M, Raczyńska-Witońska G: Distribution of
substance P nerve fibers in osteoarthritis knee joint. Pol J Pathol 2005,
56:203-6.
48. Ferreira-Gomes J, Adães S, Castro-Lopes JM: Assessment of movement-
evoked pain in osteoarthritis by the knee-bend and CatWalk tests: a
clinically relevant study. J Pain 2008, 9:945-954.
49. Sekiguchi M, Shirasaka M, Konno S, Kikuchi S: Analgesic effect of
percutaneously absorbed non-steroidal anti-inflammatory drugs: an
experimental study in a rat acute inflammation model. BMC Musculoskelet
Disord 2008, 9:15.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2474/12/134/prepub
doi:10.1186/1471-2474-12-134
Cite this article as: Orita et al.: Pain-related sensory innervation in
monoiodoacetate-induced osteoarthritis in rat knees that gradually
develops neuronal injury in addition to inflammatory pain. BMC
Musculoskeletal Disorders 2011 12:134.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Orita et al. BMC Musculoskeletal Disorders 2011, 12:134
http://www.biomedcentral.com/1471-2474/12/134
Page 12 of 12